Characterization of BCAR4, a novel oncog
โ
Marcia Godinho; Danielle Meijer; Buddy Setyono-Han; Lambert C.J. Dorssers; Ton v
๐
Article
๐
2011
๐
John Wiley and Sons
๐
English
โ 406 KB
Resistance to the antiestrogen tamoxifen remains a major problem in the management of estrogen receptor-positive breast cancer. Knowledge on the resistance mechanisms is needed to develop more effective therapies. Breast cancer antiestrogen resistance 4 (BCAR4) was identified in a functional screen